(1)
RIVERA TERÁN, V.; Isnardi, C.; De Abreu, P.; Laurindo, I.; Alpízar Rodríguez, D. OVERLIFE OF BIOLOGIC AND SYNTHETIC TARGETED DISEASE-MODIFYING ANTIRHEUMATIC DRUGS IN PATIENTS WITH INFLAMMATORY ARTHRITIS: DATA FROM FIVE LATIN AMERICAN COUNTRIES. Invest. Discapacidad 2025, 11.